These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 16154423

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Effect of DL-sodium lactate infusion on excretion of purine bases and oxypurinol.
    Yamamoto T, Moriwaki Y, Takahashi S, Nasako Y, Higashino K.
    Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):588-92. PubMed ID: 8314359
    [Abstract] [Full Text] [Related]

  • 23. [Xanthinuria with xanthine lithiasis in a patient with Lesch-Nyhan syndrome under allopurinol therapy].
    Rebentisch G, Stolz S, Muche J.
    Aktuelle Urol; 2004 Jun; 35(3):215-21. PubMed ID: 15258855
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of allopurinol in patients with the Lesch-Nyhan syndrome and partial hypoxanthine- phosphoribosyltransferase deficiency: a follow-up study of 18 Spanish patients.
    Torres RJ, Prior C, Puig JG.
    Nucleosides Nucleotides Nucleic Acids; 2006 Jun; 25(9-11):1077-82. PubMed ID: 17065067
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The effect of completely purine-free diet of low sodium content on purine intermediates and end-product.
    Yamamoto T, Yokoyama H, Moriwaki Y, Takahashi S, Suda M, Hada T, Higashino K.
    Eur J Clin Nutr; 1990 Sep; 44(9):659-64. PubMed ID: 2261897
    [Abstract] [Full Text] [Related]

  • 27. Purine metabolism in women with primary gout.
    Puig JG, Mateos FA, Miranda ME, Torres RJ, de Miguel E, Pérez de Ayala C, Gil AA.
    Am J Med; 1994 Oct; 97(4):332-8. PubMed ID: 7942934
    [Abstract] [Full Text] [Related]

  • 28. Difference of the plasma concentration and urinary excretion of allopurinol, oxypurinol, and purine bases between dietary intake and fasting.
    Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Yamakita J, Higashino K.
    Int J Clin Pharmacol Ther; 1996 Apr; 34(4):157-62. PubMed ID: 8861734
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Effect of thiopurinol on renal uric acid and oxypurine excretion in man under modified formula diet with a constant purine content].
    Griebsch A, Zöllner N.
    Verh Dtsch Ges Inn Med; 1975 Apr; 81():1462-6. PubMed ID: 1226997
    [No Abstract] [Full Text] [Related]

  • 31. Enhanced purine salvage during allopurinol therapy: an important pharmacologic property in humans.
    Edwards NL, Recker D, Airozo D, Fox IH.
    J Lab Clin Med; 1981 Nov; 98(5):673-83. PubMed ID: 7299239
    [Abstract] [Full Text] [Related]

  • 32. The effect of high-intensity training on purine metabolism in man.
    Hellsten-Westing Y, Balsom PD, Norman B, Sjödin B.
    Acta Physiol Scand; 1993 Dec; 149(4):405-12. PubMed ID: 8128888
    [Abstract] [Full Text] [Related]

  • 33. Effect of beer on the plasma concentrations of uridine and purine bases.
    Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Ka T, Fukuchi M, Hada T.
    Metabolism; 2002 Oct; 51(10):1317-23. PubMed ID: 12370853
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Influence of allopurinol and two diets on 24-hour urinary excretions of uric acid, xanthine, and ammonia by healthy dogs.
    Bartges JW, Osborne CA, Felice LJ, Unger LK, Chen M.
    Am J Vet Res; 1995 May; 56(5):595-9. PubMed ID: 7661453
    [Abstract] [Full Text] [Related]

  • 36. Effects of caffeine on prolonged intermittent-sprint ability in team-sport athletes.
    Schneiker KT, Bishop D, Dawson B, Hackett LP.
    Med Sci Sports Exerc; 2006 Mar; 38(3):578-85. PubMed ID: 16540848
    [Abstract] [Full Text] [Related]

  • 37. Uric acid excretion in healthy subjects: a nomogram to assess the mechanisms underlying purine metabolic disorders.
    Puig JG, Torres RJ, de Miguel E, Sánchez A, Bailén R, Banegas JR.
    Metabolism; 2012 Apr; 61(4):512-8. PubMed ID: 22001332
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII.
    Mineo I, Kono N, Hara N, Shimizu T, Yamada Y, Kawachi M, Kiyokawa H, Wang YL, Tarui S.
    N Engl J Med; 1987 Jul 09; 317(2):75-80. PubMed ID: 3473284
    [Abstract] [Full Text] [Related]

  • 40. Purine metabolism and inhibition of xanthine oxidase in severely hypoxic neonates going onto extracorporeal membrane oxygenation.
    Marro PJ, Baumgart S, Delivoria-Papadopoulos M, Zirin S, Corcoran L, McGaurn SP, Davis LE, Clancy RR.
    Pediatr Res; 1997 Apr 09; 41(4 Pt 1):513-20. PubMed ID: 9098853
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.